OverviewSuggest Edit

Vivos is a late stage radiation oncology focused medical device company engaged in the development of yttrium-90 based brachytherapy devices for the treatment of non resectable tumors. The Company is engaged in the development of RadioGel, an Yttrium-90 based brachytherapy device, for the treatment of tumors.

TypePublic
Founded2006
HQKennewick, US
Websiteradiogel.com

Latest Updates

Employees (est.) (Feb 2019)2(-50%)
Share Price (Oct 2017)$0.1 (-19%)

Vivos Office Locations

Vivos has an office in Kennewick
Kennewick, US (HQ)
Kennewick, WA, USA
Show all (1)

Vivos Financials and Metrics

Vivos Revenue

Market capitalization (8-Oct-2018)

2.8m
Vivos's current market capitalization is $2.8 m.
Show all financial metrics

Vivos Online and Social Media Presence

Embed Graph

Vivos News and Updates

Benco Dental announces strategic alliance with Vivos Therapeutics, Inc.

Vivos and Benco Dental will collaborate to help make all dentists in the United States aware of the company's unique apnea treatment. Vivos and Benco Dental will collaborate to help make all dentists in the United States aware of the company's unique apnea treatment.

Vivos Inc. Issues Corrective Press Release Regarding Reverse Stock Split

Richland, WA, June 27, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (the “Company”) (OTC PINK: RDGL), a company engaged in the development and commercialization of minimally invasive brachytherapy treatments to combat cancer in animals and humans, is issuing this press release to correct its press release…

Vivos Inc. Announces Expanded Applications of IsoPet® for Veterinary Cancer Therapy

Richland WA, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTCPINK: RDGL), announced that the device classification obtained from the FDA Center for Veterinary Medicine (CVM) is not limited to canine and feline sarcomas, and can be extended to a much broader population of veterinary cancers, esse…

Vivos Inc. to Treat Advanced Canine Patient for Soft Tissue Sarcoma with IsoPet®

Richland, WA, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) a pharmaceutical company in the process of researching and developing minimally invasive treatments to combat cancer in humans and animals, has agreed to supply IsoPet® to treat a dog with advanced cancer at the Universi…

Vivos Therapeutics, Inc. Announces New Chief Financial Officer

DENVER, Nov. 27, 2018 /PRNewswire/ -- Vivos Therapeutics, a company focused on addressing the root causes of mild-to-moderate sleep apnea, announced Brad Amman has joined the company as Chief Financial Officer. Mr. Amman will oversee the continued growth of Vivos Therapeutics and assist...

Vivos Therapeutics to Screen Viking Legends for Sleep Apnea at NFLPA's Professional Athletes Foundation's Health and Wellness Checkup

MINNEAPOLIS, Oct. 31, 2018 /PRNewswire/ -- Vivos Therapeutics, a company focused on addressing the root causes of mild-to-moderate sleep apnea, in partnership with the Pro Player Health Alliance, is pleased to participate in an NFL Player Association Health and Wellness Checkup on...
Show more

Vivos Blogs

Vivos Inc. Reports on IsoPet® Therapy at the Veterinary Cancer Society Annual Meeting

Vivos Inc. Reports on IsoPet® Therapy at the Veterinary Cancer Society Annual Meeting

Vivos Inc. Announces Listing to the OTCQB

Vivos Inc. Announces Listing to the OTCQB

Vivos Inc. Stock Symbol Reverts to RDGL University of Missouri Report Near Completion

Vivos Inc. Stock Symbol Reverts to RDGL University of Missouri Report Near Completion

Vivos Inc. Pilot Clinic Completes First IsoPet® Therapy

Vivos Inc. Pilot Clinic Completes First IsoPet® Therapy

Vivos Inc. Pilot Clinic Completes Their Certification Training

Vivos Inc. Pilot Clinic Completes Their Certification Training

Vivos Inc. Enhances its Intellectual Property Protection

Vivos Inc. Enhances its Intellectual Property Protection
Show more

Vivos Frequently Asked Questions

  • When was Vivos founded?

    Vivos was founded in 2006.

  • How many employees does Vivos have?

    Vivos has 2 employees.

  • Who are Vivos competitors?

    Competitors of Vivos include PhaseBio Pharmaceuticals, Charles River Laboratories International and OptiNose.

  • Where is Vivos headquarters?

    Vivos headquarters is located at Kennewick, WA, USA, Kennewick.

  • Where are Vivos offices?

    Vivos has an office in Kennewick.

  • How many offices does Vivos have?

    Vivos has 1 office.